|
Activity Number:
|
343
- SPEED: Tests, Trials, Biomarkers, and Other Topics in Biometrics
|
|
Type:
|
Contributed
|
|
Date/Time:
|
Tuesday, July 31, 2018 : 10:30 AM to 12:20 PM
|
|
Sponsor:
|
Biopharmaceutical Section
|
|
Abstract #329031
|
|
|
Title:
|
Statistical Precision of Time-to-Event Endpoint in Single Arm Observational Study Using Monte Carlo Simulation
|
|
Author(s):
|
Meijing Wu* and Hongwei Wang and Yabing Mai and Dajun Tian
|
|
Companies:
|
AbbVie and AbbVie Inc and AbbVie, Inc and Chiltern
|
|
Keywords:
|
time-to-event;
statistical precision;
Monte Carlo simulation;
single arm
|
|
Abstract:
|
Time-to-event endpoints are widely used in oncology studies. Various statistical methods have been developed for the sample size and power considerations of randomized clinical trial with time-to-event endpoints. With more observational studies being conducted for real world evidence generation, it is important to obtain some insight on the statistical precision provided by a given sample size in the observational studies using real world data. In this presentation we evaluated the statistical precision of time-to-event endpoints in single-arm observational studies via practical and applicable parametric and nonparametric methods. A Monte Carlo simulation process was conducted under the survival analysis framework incorporating both events and censored observations in multiple scenarios. Different distributions (e.g., Exponential, Weibull, and log-normal) were implemented to simulate the time-to-event and time-to-censoring data with different median survival time, drop-out rates, sample sizes and study duration. Practical guidance on the assessment of statistical precision and robustness were demonstrated with the simulated data.
|
Authors who are presenting talks have a * after their name.
Back to the full JSM 2018 program
|
